<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Yestino - The Signal · ADARx</title><link>https://yestino.com/entities/adarx-0c8eba</link><description>Every event involving ADARx</description><language>en</language><atom:link href="https://yestino.com/entities/adarx-0c8eba/feed.xml" rel="self" type="application/rss+xml"/><item><title>Drug developer ADARx seeks $1.74 billion valuation in US IPO</title><link>https://yestino.com/events/drug-developer-adarx-seeks-1-74-billion-valuation-in-us-ipo-af0493</link><guid isPermaLink="true">https://yestino.com/events/drug-developer-adarx-seeks-1-74-billion-valuation-in-us-ipo-af0493</guid><pubDate>Mon, 21 Sep 2026 17:00:42 GMT</pubDate><description>Sources: Yahoo Finance</description></item></channel></rss>